<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Fuad El-Hibri Network &#187; Insurance</title>
	<atom:link href="http://fuad-elhibri.net/tag/insurance/feed/" rel="self" type="application/rss+xml" />
	<link>http://fuad-elhibri.net</link>
	<description>Network of Fuad El-Hibri</description>
	<lastBuildDate>Mon, 30 Aug 2010 06:38:52 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Maker of anthrax vaccine discusses challenges of marketing overseas</title>
		<link>http://fuad-elhibri.net/2009/08/04/maker-of-anthrax-vaccine-discusses-challenges-of-marketing-overseas/</link>
		<comments>http://fuad-elhibri.net/2009/08/04/maker-of-anthrax-vaccine-discusses-challenges-of-marketing-overseas/#comments</comments>
		<pubDate>Tue, 04 Aug 2009 13:22:01 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[BioPort]]></category>
		<category><![CDATA[BioThrax]]></category>
		<category><![CDATA[Chairman of the Board of Directors]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Emergent]]></category>
		<category><![CDATA[Emergent BioSolutions]]></category>
		<category><![CDATA[Fuad El-Hibri]]></category>
		<category><![CDATA[Fuad Elhibri]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Insurance]]></category>
		<category><![CDATA[Master of Business Administration]]></category>
		<category><![CDATA[Risk management]]></category>
		<category><![CDATA[S.C. Johnson Graduate School of Management]]></category>

		<guid isPermaLink="false">http://fuad-elhibri.net/?p=69</guid>
		<description><![CDATA[On March 9, MBA students taking International Political Risk Management, a course taught by Elena  Iankova, a lecturer at the S.C. Johnson Graduate School of  Management, heard Fuad El-Hibri, chairman and CEO of Bioport&#8217;s parent  company, Emergent BioSolutions Inc., discuss the hurdles his firm faces  in making and marketing its products [...]]]></description>
			<content:encoded><![CDATA[<p style="text-align: justify;">On March 9, <a class="zem_slink" title="Master of Business Administration" rel="wikipedia" href="http://en.wikipedia.org/wiki/Master_of_Business_Administration">MBA</a> students taking International Political <a class="zem_slink" title="Risk management" rel="wikipedia" href="http://en.wikipedia.org/wiki/Risk_management">Risk Management</a>, a course taught by Elena  Iankova, a lecturer at the <a class="zem_slink" title="S.C. Johnson Graduate School of Management" rel="homepage" href="http://www.johnson.cornell.edu/">S.C. Johnson Graduate School of  Management</a>, heard<a href="http://www.news.cornell.edu/Chronicle/05/3.17.05/El-Hibri_cover.html"> Fuad El-Hibri</a>, <a class="zem_slink" title="Chief executive officer" rel="wikipedia" href="http://en.wikipedia.org/wiki/Chief_executive_officer">chairman and CEO</a> of Bioport&#8217;s parent  company, <a class="zem_slink" title="NYSE: EBS" rel="stockexchange" href="http://finance.yahoo.com/q?s=EBS">Emergent BioSolutions</a> Inc., discuss the hurdles his firm faces  in making and <a class="zem_slink" title="Marketing" rel="wikipedia" href="http://en.wikipedia.org/wiki/Marketing">marketing</a> its products abroad.</p>
<p style="text-align: justify;"><img src="http://www.news.cornell.edu/Chronicle/05/3.17.05/El-Hibri.jpg" alt="http://www.news.cornell.edu/Chronicle/05/3.17.05/El-Hibri.jpg" /></p>
<p style="text-align: justify;">His guest lecture was titled &#8220;Managing International Risk in the Bio-Defense and Telecommunications Industries.&#8221;</p>
<p style="text-align: justify;">Using his own company as an example, El-Hibri outlined six areas of risk in international <a class="zem_slink" title="Business" rel="wikipedia" href="http://en.wikipedia.org/wiki/Business">business</a>, among them export/import regulations, <a class="zem_slink" title="Politics" rel="wikipedia" href="http://en.wikipedia.org/wiki/Politics">politics</a> at home and abroad and financial issues. Much of his talk focused on political issues ranging from export regulations to how to deal with foreign governments.</p>
<div class="zemanta-pixie" style="margin-top: 10px; height: 15px; text-align: justify;"><a class="zemanta-pixie-a" title="Reblog this post [with Zemanta]" href="http://reblog.zemanta.com/zemified/51c4b0e3-e29f-483d-ac50-6ab2efa1597d/"><img class="zemanta-pixie-img" style="border: medium none; float: right;" src="http://img.zemanta.com/reblog_e.png?x-id=51c4b0e3-e29f-483d-ac50-6ab2efa1597d" alt="Reblog this post [with Zemanta]" /></a><span class="zem-script more-related pretty-attribution"><script src="http://static.zemanta.com/readside/loader.js" type="text/javascript"></script></span></div>
]]></content:encoded>
			<wfw:commentRss>http://fuad-elhibri.net/2009/08/04/maker-of-anthrax-vaccine-discusses-challenges-of-marketing-overseas/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
